Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is a leading competitor in the medical equipment and device industry, with a strong product portfolio and global presence. They have a history of outperforming their peers, driven by a best-in-class commercial organization and strong sales execution. While there may be some near-term disruptions, the company's sustainable growth outlook and strong management team make it a compelling investment opportunity.

Bears say

Stryker is facing a few headwinds that may hinder its growth in the future. These include a lack of execution in its growth through strategic M&A and global expansion, slowing momentum from its recent product cycles, and potential disruption from its recent cyberattack. Additionally, increasing competition in the orthopedic robotics market and slower-than-expected adoption in the ASC setting could also impact Stryker's performance. While Stryker maintains a strong competitive position and has visibility into future growth through its successful commercial playbook, these headwinds could negatively impact both its financial performance and investor sentiment.

Stryker (SYK) has been analyzed by 16 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 16 analysts, Stryker (SYK) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $394.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $394.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.